Bromodomain inhibition of the coactivators CBP/EP300 facilitate cellular reprogramming
Silencing of the somatic cell type-specific genes is a critical yet poorly understood step in reprogramming. To uncover pathways that maintain cell identity, we performed a reprogramming screen using inhibitors of chromatin factors. Here, we identify acetyl-lysine competitive inhibitors targeting th...
Hauptverfasser: | Ebrahimi, A, Sevinç, K, Sevinç, G, Cribbs, A, Philpott, M, Uyulur, F, Morova, T, Dunford, J, Göklemez, S, Arı, Ş, Oppermann, U, Onder, T |
---|---|
Format: | Journal article |
Veröffentlicht: |
Springer Nature
2019
|
Ähnliche Einträge
Ähnliche Einträge
-
Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma
von: Andrew R Conery, et al.
Veröffentlicht: (2016-01-01) -
Correction: Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma
von: Andrew R Conery, et al.
Veröffentlicht: (2016-07-01) -
Discovery and Optimization of Small-Molecule Ligands for the CBP/p300 Bromodomains
von: Hay, D, et al.
Veröffentlicht: (2014) -
Development of selective CBP/P300 benzoxazepine bromodomain inhibitors
von: Popp, T, et al.
Veröffentlicht: (2016) -
CBP/p300 bromodomain: new promising epigenetic target
von: Xiang Qiuping, et al.
Veröffentlicht: (2022-01-01)